The relationship between HIV infection and atopic dermatitis

Current Allergy and Asthma Reports

Volumn 2, Issue 4, 2002, Pages 275-281

  Rudikoff, Donald ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Allergy Clin Immunol; Atopic Dermatitis Patient; Human Immunodeficiency Virus; Human Immunodeficiency Virus Infection; Staphylococcal Superantigens

Indexed keywords

CD30 ANTIGEN; CORTICOSTEROID; CYTOKINE; IMMUNOGLOBULIN E; SUPERANTIGEN;

ATOPIC DERMATITIS; BLOOD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOLOGY; METABOLISM; OINTMENT; PHOTOTHERAPY; REVIEW; STAPHYLOCOCCUS AUREUS; TH1 CELL; TH2 CELL;

ADRENAL CORTEX HORMONES; ANTIGENS, CD30; CYTOKINES; DERMATITIS, ATOPIC; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULIN E; OINTMENTS; PHOTOTHERAPY; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS; TH1 CELLS; TH2 CELLS;

EID: 0036651399     PISSN: 15297322     EISSN: 15346315     Source Type: Journal    
DOI: 10.1007/s11882-002-0050-x     Document Type: Article

References (54)

1. Ball LM, Harper JI: Atopic eczema in HIV-seropositive haemophiliacs. Lancet 1987, 2:627–628. DOI: 10.1016/S0140-6736(87)93016-9
2. Ellaurie M, Rubinstein A, Rosenstreich DL: IgE levels in pediatric HIV-1 infection. Ann Allergy Asthma Immunol 1995, 75:332–336.
3. Morar N, Dlova N, Gupta AK, et al.: Erythroderma: a comparison between HIV positive and negative patients. Int J Dermatol 1999, 38:895–900. DOI: 10.1046/j.1365-4362.1999.00846.x
4. Ishii N, Takahashi K, Sugita Y, Nakajima H: Atopic dermatitis apparently caused by type 2 CD8+ T cells in an AIDS patient. Clin Exp Dermatol 1998, 23:121–122. DOI: 10.1046/j.1365-2230.1998.00340.x
5. Hoashi M, Imayama S, Hori Y, Kashiwagi S: An AIDS patient with atopic dermatitis-like eruption responsive to systemic anti-fungal treatment. J Dermatol 1992, 19:972–975.
6. Supanaranond W, Desakorn V, Sitakalin C, et al.: Cutaneous manifestations in HIV positive patients. Southeast Asian J Trop Med Public Health 2001, 32:171–176.
7. Saurat JH: Eczema in primary immune-deficiencies. Clues to the pathogenesis of atopic dermatitis with special reference to the Wiskott-Aldrich syndrome. Acta Derm Venereol Suppl 1985, 114:125–128.
8. Vigano A, Principi N, Crupi L, et al.: Elevation of IgE in HIVinfected children and its correlation with the progression of disease. J Allergy Clin Immunol 1995, 95:627–632. DOI: 10.1016/S0091-6749(95)70326-8
9. Koutsonikolis A, Nelson RP Jr, Fernandez-Caldas E, et al.: Serum total and specific IgE levels in children infected with human immunodeficiency virus. J Allergy Clin Immunol 1996, 97:692–697. DOI: 10.1016/S0091-6749(96)70316-0
10. Skiest DJ, Keiser P: Clinical significance of eosinophilia in HIV-infected individuals. Am J Med 1997, 102:449–453. DOI: 10.1016/S0002-9343(97)00048-X
11. Paganelli R, Fanales-Belasio E, Scala E, et al.: Serum eosinophil cationic protein (ECP) in human immunodeficiency virus (HIV) infection. J Allergy Clin Immunol 1991, 88:416–418. DOI: 10.1016/0091-6749(91)90107-Y
12. Lin RY, Lazarus TS: Asthma and related atopic disorders in outpatients attending an urban HIV clinic. Ann Allergy Asthma Immunol 1995, 74:510–515.
13. Bacot BK, Paul ME, Navarro M, et al.: Objective measures of allergic disease in children with human immunodeficiency virus infection. J Allergy Clin Immunol 1997, 100:707–711. DOI: 10.1016/S0091-6749(97)70177-5
14. Tubiolo VC, Vazzo LA, Beall GN: Food allergy in human immunodeficiency virus (HIV) infection. Ann Allergy Asthma Immunol 1997, 78:209–212.
15. Sample S, Chernoff DN, Lenahan GA, et al.: Elevated serum concentrations of IgE antibodies to environmental antigens in HIV-seropositive male homosexuals. J Allergy Clin Immunol 1990, 86:876–880. DOI: 10.1016/S0091-6749(05)80149-6
16. Sanchez-Borges M, Orozco A, Di Biagio E, et al.: Eosinophilia in early-stage human immunodeficiency virus infection. J Allergy Clin Immunol 1993, 92:494–495. DOI: 10.1016/0091-6749(93)90130-8
17. Paganelli R, Scala E, Mezzaroma I, et al.: Immunologic aspects of hyperimmunoglobulinemia E-like syndrome in patients with AIDS. J Allergy Clin Immunol 1995, 95:995–1003. DOI: 10.1016/S0091-6749(95)70100-1
18. Cone LA, Woodard DR, Byrd RG, et al.: A recalcitrant, erythematous, desquamating disorder associated with toxin-producing staphylococci in patients with AIDS. J Infect Dis 1992, 165:638–643.
19. Nakazawa M, Sugi N, Kawaguchi H, et al.: Predominance of type 2 cytokine-producing CD4+ and CD8+ cells in patients with atopic dermatitis. J Allergy Clin Immunol 1997, 99:673–682. DOI: 10.1016/S0091-6749(97)70030-7
20. Thepen T, Langeveld-Wildschut EG, et al.: Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: an immunocytochemical study. J Allergy Clin Immunol 1996, 97:828–837. DOI: 10.1016/S0091-6749(96)80161-8
21. Reinhold U, Kukel S, Goeden B, et al.: Functional characterization of skin-infiltrating lymphocytes in atopic dermatitis. Clin Exp Immunol 1991, 86:444–448. DOI: 10.1111/j.1365-2249.1991.tb02951.x
22. van Reijsen FC, Bruijnzeel-Koomen CA, Kalthoff FS, et al.: Skin-derived aeroallergen-specific T-cell clones of Th2 phenotype in patients with atopic dermatitis. J Allergy Clin Immunol 1992, 90:184–193. DOI: 10.1016/0091-6749(92)90070-I
23. Grewe M, Gyufko K, Schopf E, Krutmann J: Lesional expression of interferon-gamma in atopic eczema. Lancet 1994, 343:25–26. DOI: 10.1016/S0140-6736(94)90879-6
24. Grewe M, Walther S, Gyufko K, et al.: Analysis of the cytokine pattern expressed in situ in inhalant allergen patch test reactions of atopic dermatitis patients. J Invest Dermatol 1995, 105:407–410. DOI: 10.1111/1523-1747.ep12321078
25. Higashi N, Bang K, Gesser B, et al.: Cytokine expression of skin T-lymphocytes from patients with atopic dermatitis. Acta Derm Venereol 2001, 81:3–7. Unstimulated cultures of T-cell lines from atopic dermatitis patients expressed a type-1 profile. Stimulation with anti-CD3 and anti-CD28 monoclonal antibodies caused rapid initial upregulation of type-2 cytokines followed by a type 1 profile. Strong upregulation of interleukin-10 was observed after 24 hours of stimulation.
26. Horsmanheimo L, Harvima IT, Jarvikallio A, et al.: Mast cells are one major source of interleukin-4 in atopic dermatitis. Br J Dermatol 1994, 131:348–353. DOI: 10.1111/j.1365-2133.1994.tb08522.x
27. Snijders A, Van der Pouw Kraan TC, Engel M, et al.: Enhanced prostaglandin E2 production by monocytes in atopic dermatitis (AD) is not accompanied by enhanced production of IL-6, IL-10 or IL-12. Clin Exp Immunol 1998, 111:472–476. DOI: 10.1046/j.1365-2249.1998.00516.x
28. de Jong EC, Vieira PL, Kalinski P, et al.: Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse th cell-polarizing signals. J Immunol 2002, 168:1704–1709.
29. Kondo H, Ichikawa Y, Imokawa G: Percutaneous sensitization with allergens through barrier-disrupted skin elicits a Th2-dominant cytokine response. Eur J Immunol 1998, 28:769–779. Tape-stripping experiments in mice demonstrate allergens applied to barrier-disrupted skin induce a type-2 cytokine reaction pattern. DOI: 10.1002/(SICI)1521-4141(199803)28:03<769::AID-IMMU769>3.0.CO;2-H
30. Nissen D, Nolte H, Permin H, et al.: Evaluation of IgE-sensitization to fungi in HIV-positive patients with eczematous skin reactions. Ann Allergy Asthma Immunol 1999, 83:153–159. In HIV-positive patients with eczema, there was an IgE response against fungal antigens in the majority of patients. The IgE response was most often directed against a 46-kD main protein in the Candida albicans extract. DOI: 10.1016/S1081-1206(10)62628-2
31. Marshall JD, Chehimi J, Gri G, et al.: The interleukin-12-mediated pathway of immune events is dysfunctional in human immunodeficiency virus-infected individuals. Blood 1999, 94:1003–1011.
32. Mikovits JA, Young HA, Vertino P, et al.: Infection with human immunodeficiency virus type 1 upregulates DNA methyltransferase, resulting in de novo methylation of the gamma interferon (IFN-gamma) promoter and subsequent downregulation of IFN-gamma production. Mol Cell Biol 1998, 18:5166–5177.
33. Clerici M, Hakim FT, Venzon DJ, et al.: Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J Clin Invest 1993, 91:759–765. DOI: 10.1172/JCI116294
34. Maggi E, Mazzetti M, Ravina A, et al.: Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells. Science 1994, 265:244–248. DOI: 10.1126/science.8023142
35. Graziosi C, Pantaleo G, Gantt KR, et al.: Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIVinfected individuals. Science 1994, 265:248–252. DOI: 10.1126/science.8023143
36. Maggi E, Giudizi MG, Biagiotti R, et al.: Th2-like CD8+ T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection. J Exp Med 1994, 180:489–495. DOI: 10.1084/jem.180.2.489
37. Agarwal SK, Marshall GD Jr.: In vivo alteration in type-1 and type-2 cytokine balance: a possible mechanism for elevated total IgE in HIV-infected patients. Hum Immunol 1998, 59:99–105. DOI: 10.1016/S0198-8859(97)00261-9
38. Chehimi J, Ma X, Chouaib S, et al.: Differential production of interleukin 10 during human immunodeficiency virus infection. AIDS Res Hum Retroviruses 1996, 12:1141–9. DOI: 10.1089/aid.1996.12.1141
39. Empson M, Bishop GA, Nightingale B, Garsia R: Atopy, anergic status, and cytokine expression in HIV-infected subjects. J Allergy Clin Immunol 1999, 103:833–842. Analysis of mRNA expression in PBMCs from HIV patients by noncompetitive dot-blot PCR showed a decline in type-1 cytokine expression not accompanied by a decline in type-2 cytokines. Low constitutive in vivo expression of IL-12 mRNA significantly correlated with anergy. DOI: 10.1016/S0091-6749(99)70427-6
40. Cavagni G, Caffarelli C, Facchetti F, et al.: Cutaneous CD30+ cells in children with atopic dermatitis. Int Arch Allergy Immunol 2000, 121:224–228. CD30 expression occurs in very high proportions of infiltrating cells in childhood eczema. Total serum IgE, sCD30, sIL-2R, sCD23, and eosinophils were significantly elevated compared with controls. DOI: 10.1159/000024321
41. Frezzolini A, Paradisi M, Ruffelli M, et al.: Soluble CD30 in pediatric patients with atopic dermatitis. Allergy 1997, 52:106–109. DOI: 10.1111/j.1398-9995.1997.tb02554.x
42. Bengtsson A, Holm L, Back O, et al.: Elevated serum levels of soluble CD30 in patients with atopic dermatitis (AD). Clin Exp Immunol 1997, 109:533–537. DOI: 10.1046/j.1365-2249.1997.4731373.x
43. Yamamoto J, Adachi Y, Onoue Y, et al.: CD30 expression on circulating memory CD4+ T cells as a Th2-dominated situation in patients with atopic dermatitis. Allergy 2000, 55:1011–1018. DOI: 10.1034/j.1398-9995.2000.00685.x
44. Smith KJ, Barrett TL, Neafie R, et al.: Is CD30 (Ki-1) immunostaining in cutaneous eruptions useful as a marker of Th1 to Th2 cytokine switching and/or as a marker of advanced HIV-1 disease? Br J Dermatol 1998, 138:774–779. DOI: 10.1046/j.1365-2133.1998.02212.x
45. Hamann D, Hilkens CM, Grogan JL, et al.: CD30 expression does not discriminate between human Th1- and Th2-type T cells. J Immunol 1996, 156:1387–1391.
46. Nakamura T, Lee RK, Nam SY, et al.: Reciprocal regulation of CD30 expression on CD4+ T cells by IL-4 and IFN-gamma. J Immunol 1997, 158:2090–2098.
47. Del Prete G, Maggi E, Pizzolo G, Romagnani S: CD30, Th2 cytokines and HIV infection: a complex and fascinating link. Immunol Today 1995, 16:76–80. DOI: 10.1016/0167-5699(95)80092-1
48. Patella V, Florio G, Petraroli A, Marone G: HIV-1 gp120 induces IL-4 and IL-13 release from human Fc epsilon RI+ cells through interaction with the VH3 region of IgE. J Immunol 2000, 164:589–595. HIV gp120, which acts as a viral superantigen, interacts with the VH3 region of IgE to induce the release of IL-4 and IL-13 from human FceRI+ cells.
49. de Paulis A, De Palma R, Di Gioia L, et al.: Tat protein is an HIV-1-encoded beta-chemokine homolog that promotes migration and up-regulates CCR3 expression on human Fc epsilon RI+ cells. J Immunol 2000, 165:7171–7179. Tat protein, an HIV-1-encoded beta-chemokine homologue, influences the directional migration of human FceRI(+) cells and the expression of surface receptor CCR3 on these cells.
50. Li Y, Li L, Wadley R, et al.: Mast cells/basophils in the peripheral blood of allergic individuals who are HIV-1 susceptible due to their surface expression of CD4 and the chemokine receptors CCR3, CCR5, and CXCR4. Blood 2001, 97:3484–3490. Mast cells and basophils in the blood of HIV-infected patients are susceptible to infection by M-tropic HIV-1 strains. DOI: 10.1182/blood.V97.11.3484
51. Skov L, Olsen JV, Giorno R, et al.: Application of Staphylococcal enterotoxin B on normal and atopic skin induces up-regulation of T cells by a superantigen-mediated mechanism. J Allergy Clin Immunol 2000, 105:820–826. DOI: 10.1067/mai.2000.105524
52. Zollner TM, Wichelhaus TA, Hartung A, et al.: Colonization with superantigen-producing Staphylococcus aureus is associated with increased severity of atopic dermatitis. Clin Exp Allergy 2000, 30:994–1000. Colonization with superantigen-producing strains of Staphylococcus aureus correlates with increased severity of atopic dermatitis as a result of a superantigen effect rather than a direct allergenic effect of the superantigen. DOI: 10.1046/j.1365-2222.2000.00848.x
53. Davison S, Allen M, Vaughan R, Barker J: Staphylococcal toxininduced T cell proliferation in atopic eczema correlates with increased use of superantigen-reactive Vbeta-chains in cutaneous lymphocyte-associated antigen (CLA)-positive lymphocytes. Clin Exp Immunol 2000, 121:181–186. DOI: 10.1046/j.1365-2249.2000.01270.x
54. Brinchmann JE, Gaudernack G, Thorsby E, Vartdal F: Staphylococcal exotoxin superantigens induce human immunodeficiency virus type 1 expression in naturally infected CD4+ T cells. J Virol 1992, 66:5924–5928.